This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Northrop Grumman's Amy Caro Says Genomic Data Will Significantly Advance Healthcare But Security Is Key

WASHINGTON, Nov. 8, 2013 /PRNewswire/ -- Speaking at the U.S. News & World Report Hospital of Tomorrow forum Tuesday, Northrop Grumman Corporation's (NYSE: NOC) Amy Caro, vice president of health IT programs, said advances in genomics and more widespread use of molecular data will enhance healthcare and improve health outcomes but ensuring the security of personal data is key to its accelerated use.

(Logo: http://photos.prnewswire.com/prnh/20121024/LA98563LOGO)

Genomics is the field of study based on identifying and analyzing a person's complete set of DNA and it is beginning to help the medical community predict, diagnose and treat various conditions, although complete genome-sequencing is not yet widely used.

Caro said genomics and proteomics, which is the study of proteins, their structures and functions, will "usher in a new era of personalized medicine, resulting in more accurate diagnoses and targeted treatments that work more effectively." She also said it could lower costs through increasing preventative care, eliminating unnecessary treatment and reducing negative outcomes such as adverse drug reactions.

As an IT systems integrator, Northrop Grumman will be serving as a "value-added facilitator" between the producers and users of this information. The company's role, Caro said, extends beyond IT integration to "incorporate increasing levels of scientific expertise to analyze and visualize data, manage data and ensure the secure exchange of information."

Northrop Grumman is currently developing a number of genomic and proteomic projects in partnership with universities and other companies, utilizing its IT expertise to enable genetic information to be integrated, analyzed and visualized for clinical purposes across healthcare systems.

"Northrop Grumman's focus on the role of information systems will accelerate the translation of genomic findings to clinical care, with the ultimate goal of helping this nation increase healthcare efficiency, reduce healthcare costs and improve health outcomes for its citizens," Caro said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs